Kian Eftekhari
University of Pennsylvania
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kian Eftekhari.
Pharmacoepidemiology and Drug Safety | 2014
Kian Eftekhari; Devon H. Ghodasra; Kevin Haynes; Jinbo Chen; John H. Kempen; Brian L. VanderBeek
The aim of this study is to determine if oral fluoroquinolone exposure is associated with an increased hazard for having a retinal tear or detachment.
Ophthalmology | 2014
Devon H. Ghodasra; Kian Eftekhari; Ankoor R. Shah; Brian L. VanderBeek
OBJECTIVE To determine the frequency of clinical management changes resulting from inpatient ophthalmic consultations for fungemia and the associated costs. DESIGN Retrospective case series. PARTICIPANTS Three hundred forty-eight inpatients at a tertiary care center between 2008 and 2012 with positive fungal blood culture results, 238 of whom underwent an ophthalmologic consultation. METHODS Inpatient charts of all fungemic patients were reviewed. Costs were standardized to the year 2014. The Student t test was used for all continuous variables and the Pearson chi-square test was used for categorical variables. MAIN OUTCOME MEASURES Prevalence of ocular involvement, rate of change in clinical management, mortality rate of fungemic patients, and costs of ophthalmic consultation. RESULTS Twenty-two (9.2%) of 238 consulted patients with fungemia had ocular involvement. Twenty patients had chorioretinitis and 2 had endophthalmitis. Only 9 patients (3.7%) had a change in management because of the ophthalmic consultation. One patient underwent bilateral intravitreal injections. Thirty percent of consulted patients died before discharge or were discharged to hospice. The total cost of new consults was
Ophthalmic Plastic and Reconstructive Surgery | 2015
Kian Eftekhari; Christopher B. Chambers; Scott M. Goldstein; William R. Katowitz; James A. Katowitz
36 927.54 (
Current Eye Research | 2014
Frank L. Brodie; Jason Ruggiero; Devon H. Ghodasra; Kian Eftekhari; James Z. Hui; Alexander J. Brucker; Brian L. VanderBeek
204.19/initial level 5 visit and
Ophthalmic Plastic and Reconstructive Surgery | 2016
Kian Eftekhari; Kenneth S. Shindler; Vivian S. Lee; Kimberly Dine; Lauren A. Eckstein; M. Reza Vagefi
138.63/initial level 4). The cost of follow-up visits was
Survey of Ophthalmology | 2015
Kian Eftekhari; Christina H. Choe; M. Reza Vagefi; Lauren A. Eckstein
13 655.44 (
Ophthalmic Plastic and Reconstructive Surgery | 2011
Kian Eftekhari; Kudakwashe R. Chikwava; William R. Katowitz
104.24/visit). On average, 26.4 patients were evaluated to find 1 patient needing change in management, with an average cost of
Journal of Neuro-ophthalmology | 2013
Kian Eftekhari; Collin M. McClelland; Roberta E. Gausas; Bo Jian; John H. Woo; Nicholas J. Volpe; Madhura A. Tamhankar
5620.33 per change in 1 patients management. CONCLUSIONS Clinical management changes resulting from ophthalmic consultation in fungemic patients were uncommon. Associated costs were high for these consults in a patient population with a high mortality rate. Together, these data suggest that the usefulness of routine ophthalmic consultations for all fungemic patients is likely to be low.
Ophthalmic Plastic and Reconstructive Surgery | 2017
Scott C. Cole; Kian Eftekhari; Thomas J. Oberg; Nick Mamalis; Richard L. Anderson
A 3-year-old child presented with a history of conjunctivitis in her OS. She had hyperglobus of the OS and a palpable mass in the left inferior orbit. An urgent MRI revealed an enhancing mass in the left orbit. The patient underwent an incisional biopsy with pathologic assessment most consistent with embryonal rhabdomyosarcoma. However, subsequent molecular genetic testing of the biopsy specimen was positive for the PAX3/PAX7-FKHR chimeric gene, indicating the tumor was actually an alveolar rhabdomyosarcoma. The patient received a more intensive chemotherapy regimen and also was treated with proton-beam radiotherapy. After chemotherapy and proton irradiation, the patients tumor shrank considerably, and she remained in remission at over 3 years of follow up. This patient illustrates the new tools at the disposal of the orbital specialist including molecular genetic testing and proton-beam irradiation to diagnose and treat orbital rhabdomyosarcoma.
Ophthalmic Plastic and Reconstructive Surgery | 2017
Scott C. Cole; Kian Eftekhari; Richard L. Anderson; Thomas J. Oberg
Abstract Background: Reflux following intravitreal injection is a common phenomenon, but it is unknown how much, if any, medication is lost as a result. Reflux is known to be a combination of vitreous and the injected agent, but the relative composition is unknown. This article describes a novel method for the measurement of the volume and composition of reflux and presents data from porcine eyes. Methods: Twenty porcine eyes were injected with 0.05 ml of dye at intraocular pressures (IOPs) of 15, 20, 25 and 30 mmHg (five eyes per subgroup). Reflux was captured on filter paper and the area of saturation and color intensity of the dye were digitally analyzed. Total refluxed volume and proportion of dye versus vitreous fluid were calculated from linear regression lines created from known standards. Results: Average (median) total volume of reflux from all eyes was 1.19 μl (0.93 μl), volume of injected dye refluxed was 0.47 μl (0.11 μl) and composition of reflux was 20.8% dye (15.5%). Less than 1% of the injected dye was lost to reflux. There were no differences between IOP groups in the total volume refluxed, the total amount of dye refluxed, the average composition of the reflux or the amount of injected dye refluxed (df = 3 for all comparisons; p = 0.58, p = 0.51, p = 0.55, p = 0.51, respectively). Conclusions: This novel method allows for measurement of quantity and composition of reflux following intravitreal injection in vitro. While reflux occurs frequently, it is predominantly composed of vitreous, not the injected agent. In fact, <1% of the original injection was lost to reflux.